Article
Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation.
Circulation - 30 Sept 2014
Adalsteinsdottir Berglind, Teekakirikul Polakit, Maron Barry J, Burke Michael A, Gudbjartsson Daniel F, Holm Hilma, Stefansson Kari, DePalma Steven R, Mazaika Erica, McDonough Barbara, Danielsen Ragnar, Seidman Jonathan G, Seidman Christine E, Gunnarsson Gunnar T
Abstract excerpt
BACKGROUND: The geographic isolation and homogeneous population of Iceland are ideally suited to ascertain clinical and genetic characteristics of hypertrophic cardiomyopathy (HCM) at the population level. METHODS AND RESULTS: Medical records and cardiac imaging studies obtained between 1997 and 2010 were reviewed to identify Icelandic patients with HCM. Surviving patients were recruited for clinical and genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.